An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

Completed · Phase 2

Conditions studied: Malignant Pleural Mesothelioma

In brief

This research is being done to find out if pemetrexed and cisplatin work better when given together with an experimental drug called MORAb-009 in patients with malignant pleural mesothelioma.

Key facts

Study ID
NCT00738582
Run by
Morphotek
People needed
89
Starts
2008-12-31
Expected to finish
2014-01-10
Last updated by the study team
2022-09-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.